CN106978417A - A kind of recognizable RNA fragments of HuR albumen and the application in HuR Activity determinations - Google Patents

A kind of recognizable RNA fragments of HuR albumen and the application in HuR Activity determinations Download PDF

Info

Publication number
CN106978417A
CN106978417A CN201710198729.8A CN201710198729A CN106978417A CN 106978417 A CN106978417 A CN 106978417A CN 201710198729 A CN201710198729 A CN 201710198729A CN 106978417 A CN106978417 A CN 106978417A
Authority
CN
China
Prior art keywords
hur
luciferase
activity
cell
post
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710198729.8A
Other languages
Chinese (zh)
Other versions
CN106978417B (en
Inventor
郑丽端
童强松
陈亚俊
杨枫
李欢欢
叶霖
李聃
宋华杰
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tongji Medical College of Huazhong University of Science and Technology
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Original Assignee
Union Hospital Tongji Medical College Huazhong University of Science and Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Union Hospital Tongji Medical College Huazhong University of Science and Technology filed Critical Union Hospital Tongji Medical College Huazhong University of Science and Technology
Priority to CN201710198729.8A priority Critical patent/CN106978417B/en
Publication of CN106978417A publication Critical patent/CN106978417A/en
Application granted granted Critical
Publication of CN106978417B publication Critical patent/CN106978417B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The present invention relates to the RNA fragments that a kind of HuR albumen can recognize that, it is characterised in that by SEQ ID NO:DNA sequence dna transcription shown in 1 is obtained;Further relate to the application of the RNA fragments;Further relate to a kind of method for being used to detect intracellular HuR post-transcriptional controls activity.By using the DNA fragmentation and method of the present invention, intracellular HuR post-transcriptional control activity can be detected directly against property, rather than the content of its transcript or protein is only detected, it is enable to more accurately analyze effects of the HuR as mRNA binding factors played in some Developmental Biology and pathological development.

Description

A kind of recognizable RNA fragments of HuR albumen and the application in HuR Activity determinations
Technical field
The present invention relates to biology field, more specifically it relates to a kind of recognizable RNA fragments of HuR albumen and its Application in intracellular HuR post-transcriptional controls activity is detected.
Background technology
Human antigen R (human antigen R, HuR) belongs to embryonic death abnormal vision in rna binding protein (embryonic lethal abnormalvision, ELAV) family, ELAV families include 4 members:HuB, HuC, HuD and HuR, preceding 3 members are main to express in nerve fiber and reproductive organs, and relevant with neurodevelopment.Recent study shows, HuR played stably in target gene post-transcriptional control mRNA and promote translation effect.Multinomial experiment is confirmed:The target that HuR is combined The factor is mostly oncogene, tumor suppressor gene and tumorigenic regulatory factor, thus the generation of HuR and kinds of tumors, development and pre- It is closely related afterwards.The generation of HuR and human breast carcinoma, colorectal cancer, cervical carcinoma, oophoroma and stomach cancer, attack and shift relevant, can Can influence the key factor of tumorigenesis and prognosis.
HuR is a kind of mRNA associated proteins, and its activity form can be combined with mRNA 3 '-UTR, and be come by this way Regulate and control mRNA stability and translation efficiency.Therefore, the research for HuR needs to detect HuR activity form.
However, endogenous HuR still relies on is Western Blot technologies for detection at present, although sensitivity is high, but inspection The difference of the simply HuR protein contents measured, can not directly embody the change of its activation level.
Accordingly, it would be desirable to design a kind of new method for being used to detect intracellular HuR post-transcriptional controls activity.
The content of the invention
Inventor has found there are 3 RNA identification blocks (RRMs) on HuR albumen by studying, can be with AREs certain bits Point is combined.RRM1 and RRM2 is combined with rich in U/A copy sequences.RRM3 is closed with poly (A) caudal knot, and help maintains RNA albumen to answer The stabilization of compound.By analysis, inventor has found, by SEQ ID NO:The RNA sequence of sequential coding shown in 1 is connected on mRNA During 3 ' end, HuR albumen can effectively combine the 3rd ' area of the mRNA, activate the stability that the mRNA is translated and improved mRNA.
Studied based on more than, the invention provides the RNA fragments that a kind of HuR albumen can recognize that, it is by SEQ ID NO:1 institute The DNA sequence dna transcription shown is obtained.
Present invention also offers application of the above-mentioned RNA fragments in intracellular HuR post-transcriptional controls activity is detected.
Present invention also offers a kind of method for being used to detect intracellular HuR post-transcriptional controls activity, it includes following step Suddenly:
S1:Reporter System comprising reporter gene expression frame is imported into the cell, the reporter gene expression frame 3 '-UTR areas include SEQ ID NO:DNA fragmentation shown in 1;
S2:The intracellular HuR post-transcriptional controls activity is calculated by detecting the expression of the reporter gene.It will can report The expression intensity of gene is accused as the index for indicating HuR post-transcriptional controls activity.
Preferably, the Reporter System be dual-luciferase reporter system, including luciferase I expression cassettes and Luciferase II expression cassettes, the DNA fragmentation is connected to 3 '-UTR areas of luciferase I expression cassettes, and the luciferase I is excited The wavelength of fluorescence of generation is different from luciferase II.HuR post-transcriptional control activity is expressed as luciferase I and excites the glimmering of generation Luminous intensity excites the ratio of the fluorescence intensity of generation with luciferase II.
Preferably, luciferase I expression cassettes and luciferase the II expression cassette is on same carrier.
Preferably, the dual-luciferase reporter system by the DNA fragmentation by being inserted into plasmid psiCHECK 3 '-UTR areas of middle renilla luciferase gene are obtained.
Preferably, S1 is specifically included:
S11:By the cell culture to adherent, and recover form;
S12:The Reporter System is transfected into cell.
Preferably, S2 is specifically included:
S21:Cell is continued into culture 24-36 hours after transfection, cell is washed;
S22:Luciferase I respectively in the cell after detection transfection and luciferase II activity;
S23:Luciferase II activity normalization luciferase I activity is obtained into value as HuR post-transcriptional controls are weighed to live The index of property.
By using the RNA fragments and method of the present invention, intracellular HuR post-transcriptional control can be detected directly against property Activity, rather than only detect the content of its transcript or protein, is enable to more accurately to analyze HuR and is tied as mRNA Close effect of the factor played in some Developmental Biology and pathological development.
Brief description of the drawings
Fig. 1 is that Xho I and Not I carry out the agarose gel photograph after double digestion to recombinant plasmid;
Fig. 2 has psiCHECK2 and psiCHECK2-HuR-RLu human prostate cancer cell line PC-3, people for transfection respectively Relative HuR activity in cervical cancer tumer line HeLa and human embryonic kidney cell line's HEK-293T cells (that is, live by firefly luciferase Property with renilla luciferase activity ratio) statistical chart;
Fig. 3 has pcDNA-TAP (that is, empty carrier) and pcDNA-TAP-HuR human prostate cancer cell line for transfection respectively (that is, firefly is glimmering for relative HuR activity in PC-3, Human cervical cancer cell lines HeLa and human embryonic kidney cell line's HEK-293T cells The ratio of light element enzymatic activity and renilla luciferase activity) statistical chart.
Embodiment
The principle and feature of the present invention are described below in conjunction with example, the given examples are served only to explain the present invention, and It is non-to be used to limit the scope of the present invention.
1. build the DNA encoding sequence of the combinative RNA fragments of HuR albumen
Inventor researchs and analyses to HuR, finds the mRNA core sequences of HuR combinations, goes out to compile with reference to the sequences Design The DNA encoding sequence of the code combinative RNA fragments of HuR albumen, its sequence such as SEQ ID NO:Shown in 1.It is connected to psiCHECKTM- 2Vector renilla luciferases gene (hRluc) downstream site, i.e. hRluc 3'-UTR areas, constitute hRluc- HuR target RNA motif-hLuc luciferase reporter gene plasmids.
To ensure the success of vector construction, the cohesive end of corresponding restriction enzyme digestion sites is added in end, This example adds the cohesive end (CTCGAG) of Xho I restriction enzyme sites at 5 ' ends, and the viscosity end of Not I restriction enzyme sites is added at 3 ' ends Hold (GCGGCCGC), the design of the cohesive end on sequence both sides contributes to the connection of fragment and carrier.
By the method for de novo formation, two oligonucleotide chains of the fragment are respectively synthesized, its sequence is respectively such as SEQ ID NO:Shown in 2 and 3.5 ' ends are formed after two oligonucleotide chain complementary pairings and include Xho I restriction enzyme sites cohesive ends and 3 ' end bags The double-stranded DNA of the restriction enzyme site cohesive ends of I containing Not.100 μ l annealing systems are as follows:Annealing Buffer for DNA The μ l of Oligos (5X) 20, oligonucleotide chain (50 μM) each 20 μ l, remainder are ddH2O。
After fully mixing, PCR instrument program is set to carry out annealing reaction, specific procedure is:95 DEG C are annealed that (purpose is 2 minutes DNAoligo is allowed fully to be denatured);Decline 1 DEG C within every 90 seconds, be down to after 25 DEG C and terminate reaction.DNA annealed products are with 1.5% common fine jade Sepharose electroresis appraisal, surveys concentration rearmounted standby on ice.
2. above-mentioned DNA fragmentation is inserted into Luciferase Expression Vectors
The luciferase expression reporter plasmid that the embodiment of the present invention is selected is psiCHECKTM2 plasmids.With restricted interior Enzyme cutting Xho I and Not I (are purchased from TAKARA companies, Xho I article No.s are that 1635, Not I article No.s are 1623) to above-mentioned psiCHECKTM2 plasmids carry out double digestion, and 20 μ l digestion systems are as follows:10x QuickCut Green buffer 2 μ l, Xho I 1 μ l, Not I 1 μ l, psiCHECKTMThe μ g of 2 empty carrier 1, remainder is ddH2O。
After fully mixing, 37 DEG C of endonuclease reactions 90 minutes identify plasmid double digestion with the sugared gel electrophoresis of 1.5% plain agar Situation afterwards, then gel extraction (DNA glue reclaims kit is purchased from Tiangeng biochemical technology Co., Ltd, and article No. is DP209), returns Receipts survey sample concentration after terminating, and put standby on ice.
The double-stranded DNA that annealing is obtained is connected to psiCHECKTMOn 2 plasmid encoding luciferases element enzyme reporter plasmid.10 μ l connect Junctor system is as follows:DNA ligase (be purchased from TAKARA companies, article No. is 6022) 5 μ l, double chain DNA fragment with through double digestion psiCHECKTM2 carriers totally 5 μ l.To promote enzyme to be linked to be power, the mol ratio of DNA fragmentation and carrier is controlled 8:1 or so.Fill Divide after mixing, enzyme disjunctor system is placed in PCR instrument, 16 DEG C are reacted 1 hour, and coupled reaction obtains recombinant plasmid after terminating, and is placed in It is standby on ice.
By recombinant plasmid (containing coding HuR albumen can binding site DNA sequence dna psiCHECKTM2 reporter gene matter Grain) convert to Escherichia coli.Specific method is as follows:The competence bacillus coli DH 5 alpha after thawing is taken, above-mentioned connect is added Recombinant plasmid, soft piping and druming is incubated 20 minutes on ice, 42 DEG C of heat shocks 60 seconds, stands 3 minutes on ice, then adds 450 μ l not LB fluid nutrient mediums containing antibiotic, are positioned over 1 hour (37 DEG C, 200rpm) of recovery in constant-temperature table.Take the bacterium solution after recovery To being covered with solid medium (containing ampicillin) culture dish, bacterium solution is equably paved with to whole plate with glass paving bacterium device, After placing 10 minutes, it is inverted in after 37 DEG C of incubators stay overnight, observes bacterial growth situation.Picking colony is to 5ml containing ampicillin LB fluid nutrient mediums, shake after bacterium (37 DEG C, 200rpm) breeds 12 hours and extract plasmid, the sugar gel electrophoresis of 1.5% plain agar Identification.
Double digestion identification, double digestion of the embodiment of the present invention are carried out to the plasmid of said extracted with restriction endonuclease Xho I and Not I Identification is as shown in Figure 1 (swimming lane 1 is marker, and swimming lane 1-3 is shown as positive colony).Deliver to Wuhan for positive group and hold up section's biotechnology Co., Ltd is sequenced, and confirms that DNA fragmentation has been integrated into psiCHECKTMOn -2Vector reporter plasmids.So far, containing coding HuR albumen can binding site DNA fragmentation psiCHECKTM2 reporter plasmids (are represented as psiCHECK2-HuR- below RLuc) successfully construct.
3.psiCHECK2-HuR-RLuc transfectional cells
The embodiment of the present invention uses human prostate cancer cell line PC-3, Human cervical cancer cell lines HeLa, human embryonic kidney cell line HEK-293T carries out Dual-Luciferase experiment.The cell that logarithmic phase grows uniformly is planted in 24 orifice plates respectively, per hole about 10 Ten thousand cells, use 10% hyclone, and DMEM in high glucose medium culture is stayed overnight.After cell attachment and after recovering form, it will report Genic system related plasmids are transfected into cell (cell density is about that 60-80% is advisable during transfection).The transfection reagent used is Neofect (purchased from zero objective Powerise bio tech ltd, article No. is TF20121201).50 μ l rotaring redyeing systems are as follows:Plasmid The μ l of 0.5 μ g, Neofect transfection reagent 0.5, remainder is serum free medium.
The plasmid used in this experiment is respectively:psiCHECKTM- 2Vector reporter plasmids, psiCHECK2-HuR- RLuc (containing coding HuR albumen can binding site DNA fragmentation psiCHECKTM- 2Vector reporter plasmids), PcDNA-TAP (empty plasmid), pcDNA-TAP-HuR (HuR is overexpressed plasmid).
4. calculate HuR activity
It is standardized using firefly luciferase activity as internal reference, calculates HuR activity.Specific experiment method is as follows: Cell after transfection continues to cultivate 24-36 hours, then abandons culture medium supernatant, cell is cleaned with 1xPBS 3 times, 5 minutes every time, clearly Notice that operation is soft when washing cell, it is to avoid front piping and druming cell.Using dual luciferase reporter gene detection kit (purchased from lid Peaceful biotechnology has new company, and article No. is GN201-01) detected.
Whether the embodiment of the present invention is active for checking this report genic system, by psiCHECKTM- 2 plasmids and PsiCHECK2-HuR-RLuc plasmid transfections into cell, the activity of examining report genic system, measurement result as shown in Fig. 2 The relative luciferase activity for the treatment of group (transfection psiCHECK2-HuR-RLuc) (transfects psiCHECK apparently higher than control groupTM- 2 empty carriers).
Whether the embodiment of the present invention can be with specific detection HuR activity, by pcDNA-TAP for checking this report genic system Plasmid and pcDNA-TAP-HuR plasmids are transfected to cell, as a result as shown in figure 3, external source is imported after HuR, positive treatment group respectively (transfection pcDNA-TAP-HuR) fluorescence activity is apparently higher than control group (transfection pcDNA-TAP empty carriers).
The foregoing is only presently preferred embodiments of the present invention, be not intended to limit the invention, it is all the present invention spirit and Within principle, any modification, equivalent substitution and improvements made etc. should be included in the scope of the protection.
Sequence table
<110>Wuhan Union Hospital
<120>A kind of recognizable RNA fragments of HuR albumen and the application in HuR Activity determinations
<130> 1
<160> 3
<170> PatentIn version 3.5
<210> 1
<211> 66
<212> DNA
<213>Artificial sequence
<400> 1
tggataccgt tcgttgttaa ccgttgatag ccttggtttt taagccgtat atggctgtaa 60
ataatt 66
<210> 2
<211> 73
<212> DNA
<213>Artificial sequence
<400> 2
tcgagtggat accgttcgtt gttaaccgtt gatagccttg gtttttaagc cgtatatggc 60
tgtaaataat tgc 73
<210> 3
<211> 73
<212> DNA
<213>Artificial sequence
<400> 3
ggccgcaatt atttacagcc atatacggct taaaaaccaa ggctatcaac ggttaacaac 60
gaacggtatc cac 73

Claims (8)

1. the recognizable RNA fragments of a kind of HuR albumen, it is characterised in that by SEQ ID NO:DNA sequence dna shown in 1 is transcribed Arrive.
2. application of the RNA fragments in intracellular HuR post-transcriptional controls activity is detected described in claim 1.
3. a kind of method for being used to detect intracellular HuR post-transcriptional controls activity, it is characterised in that comprise the following steps:
S1:Reporter System comprising reporter gene expression frame is imported into the cell, the reporter gene expression frame 3 '- UTR areas include SEQ ID NO:DNA fragmentation shown in 1;
S2:The intracellular HuR post-transcriptional controls activity is calculated by detecting the expression of the reporter gene.
4. method according to claim 3, it is characterised in that the Reporter System is luciferase reporter gene System, including luciferase I expression cassettes and luciferase II expression cassettes, the DNA fragmentation are connected to luciferase I expression cassettes 3 '-UTR areas, the luciferase I excites the wavelength of fluorescence of generation different from luciferase II.
5. method according to claim 4, it is characterised in that luciferase I expression cassettes and luciferase the II expression Frame is on same carrier.
6. method according to claim 5, it is characterised in that the dual-luciferase reporter system passes through by described in The 3 '-UTR areas that DNA fragmentation is inserted into renilla luciferase gene in plasmid psiCHECK are obtained.
7. the method according to any one of claim 4-6, it is characterised in that S1 is specifically included:
S11:By the cell culture to adherent, and recover form;
S12:The Reporter System is transfected into cell.
8. method according to claim 7, it is characterised in that S2 is specifically included:
S21:Cell is continued into culture 24-36 hours after transfection, cell is washed;
S22:Luciferase I respectively in the cell after detection transfection and luciferase II activity;
S23:The value that luciferase II activity normalization luciferase I activity is obtained is active as HuR post-transcriptional controls are weighed Index.
CN201710198729.8A 2017-03-29 2017-03-29 RNA fragment capable of being identified by HuR protein and application of RNA fragment in HuR activity detection Active CN106978417B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710198729.8A CN106978417B (en) 2017-03-29 2017-03-29 RNA fragment capable of being identified by HuR protein and application of RNA fragment in HuR activity detection

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710198729.8A CN106978417B (en) 2017-03-29 2017-03-29 RNA fragment capable of being identified by HuR protein and application of RNA fragment in HuR activity detection

Publications (2)

Publication Number Publication Date
CN106978417A true CN106978417A (en) 2017-07-25
CN106978417B CN106978417B (en) 2020-02-21

Family

ID=59339785

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710198729.8A Active CN106978417B (en) 2017-03-29 2017-03-29 RNA fragment capable of being identified by HuR protein and application of RNA fragment in HuR activity detection

Country Status (1)

Country Link
CN (1) CN106978417B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106399461A (en) * 2016-09-14 2017-02-15 妙顺(上海)生物科技有限公司 Method of detection of transcription factor expression activity by luciferase reporter gene system

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106399461A (en) * 2016-09-14 2017-02-15 妙顺(上海)生物科技有限公司 Method of detection of transcription factor expression activity by luciferase reporter gene system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
WANG HONG等: "《The structure of the ARE-binding domains of Hu antigen R (HuR) undergoes conformational changes during RNA binding》", 《ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY》 *
明洁: "《"HuR依赖性mRNA稳定性对p27Kip1的转录后表达调控》", 《中国博士学位论文全文数据库 医药卫生科技辑》 *

Also Published As

Publication number Publication date
CN106978417B (en) 2020-02-21

Similar Documents

Publication Publication Date Title
US11168324B2 (en) Crispr DNA targeting enzymes and systems
Lacroix et al. The VirE3 protein of Agrobacterium mimics a host cell function required for plant genetic transformation
Chen et al. A highly efficient transient protoplast system for analyzing defence gene expression and protein–protein interactions in rice
KR101771373B1 (en) Methods and materials using signaling probes
ES2423598T3 (en) Selection and isolation of living cells using probes that bind mRNA
Bai et al. A protein-independent fluorescent RNA aptamer reporter system for plant genetic engineering
US20220315913A1 (en) Novel crispr dna targeting enzymes and systems
Luo et al. Recombinase polymerase amplification/Cas12a-based identification of Xanthomonas arboricola pv. pruni on peach
CA3152788A1 (en) Novel crispr dna targeting enzymes and systems
Youseff et al. RNAi-based gene silencing using a GFP sentinel system in Histoplasma capsulatum
Mehta et al. High-efficiency knock-in of degradable tags (dTAG) at endogenous loci in cell lines
CN106978417A (en) A kind of recognizable RNA fragments of HuR albumen and the application in HuR Activity determinations
EP2142640B1 (en) Identifying germline competent embryonic stem cells
CN113373102B (en) Photosynthetic bacteria for detecting explosives and preparation method and application thereof
CN110656119B (en) Expression vector for observing bacterial protein localization and construction method thereof
US20230031446A1 (en) Split-enzyme system to detect specific dna in living cells
Geny et al. Tagging Proteins with Fluorescent Reporters Using the CRISPR/Cas9 System and Double-Stranded DNA Donors
CN107034219B (en) GATA2 protein bindable DNA fragment and application thereof in activity detection of GATA2
WO2014015227A1 (en) Engineering cell surfaces for orthogonal selectability
CN106754866B (en) Promoter library and construction method thereof
CN107460192B (en) C-Myc protein bindable DNA fragment and application thereof in c-Myc activity detection
CN102766629B (en) Cloning and identification of swine muscle specific MLC2 promoter and application thereof
Kueblbeck et al. Rapid generation of homozygous fluorescent knock-in human cells using CRISPR/Cas9 genome editing and validation by automated imaging and digital PCR screening
CN107034214A (en) A kind of CTCF albumen can combine DNA fragmentation and the application in CTCF Activity determinations
Earnest-Noble et al. Two isoleucyl tRNAs that decode ‘synonymous’ codons divergently regulate breast cancer progression

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant